ZA964668B - Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors. - Google Patents

Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors.

Info

Publication number
ZA964668B
ZA964668B ZA9604668A ZA964668A ZA964668B ZA 964668 B ZA964668 B ZA 964668B ZA 9604668 A ZA9604668 A ZA 9604668A ZA 964668 A ZA964668 A ZA 964668A ZA 964668 B ZA964668 B ZA 964668B
Authority
ZA
South Africa
Prior art keywords
metalloprotease
amino
hydroxamic acid
tnf inhibitors
carboxylate compounds
Prior art date
Application number
ZA9604668A
Inventor
Chu-Biao Xue
Carl Peter Decicco
William F Degrado
Irina Cipora Jacobson
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Priority to ZA9604668A priority Critical patent/ZA964668B/en
Publication of ZA964668B publication Critical patent/ZA964668B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA9604668A 1996-06-05 1996-06-05 Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors. ZA964668B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA9604668A ZA964668B (en) 1996-06-05 1996-06-05 Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA9604668A ZA964668B (en) 1996-06-05 1996-06-05 Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors.

Publications (1)

Publication Number Publication Date
ZA964668B true ZA964668B (en) 1998-02-25

Family

ID=25585729

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604668A ZA964668B (en) 1996-06-05 1996-06-05 Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors.

Country Status (1)

Country Link
ZA (1) ZA964668B (en)

Similar Documents

Publication Publication Date Title
IL128663A0 (en) 1,4-heterocyclic metalloprotease inhibitors
IL128661A0 (en) 1,3-diheterocyclic metalloprotease inhibitors
ZA979238B (en) The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors.
AU3102397A (en) Metalloprotease inhibitors
IL144783A0 (en) Sulfamato hydroxamic acid metalloprotease inhibitor
ZA977700B (en) Phosphinic acid amides as matrix metalloprotease inhibitors.
HUP0101613A2 (en) Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same
AU5665396A (en) Novel hydroxamic acid and amino-carboxylate compounds as met alloprotease and tnf inhibitors
IL128664A0 (en) Heterocyclic metalloprotease inhibitors
ZA979236B (en) The preparation and use of ß-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors.
PL343529A1 (en) Substituted pyrrolidine hydroxamate metalloprotease inhibitors
GB9401129D0 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
IL128667A0 (en) Spirocyclic metalloprotease inhibitors
IL128665A0 (en) Bidenatate metalloprotease inhibitors
ZA981532B (en) Reverse hydroxamate derivatives as matrix metalloprotease inhibitors, metalloprotease inhibitors, and TNF alpha inhibitors.
ZA979756B (en) Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors.
IL125381A0 (en) Hydroxamic acid based collagenase inhibitors
ZA974033B (en) Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors.
GB9624817D0 (en) Metalloproteinase inhibitors
HK1021637A1 (en) Hydroxamic acid derivatives
ZA964668B (en) Hydroxamic acid and amino-carboxylate compounds as metalloprotease and TNF inhibitors.
ZA964660B (en) Hydroxamic and carbocyclic acids as metalloprotease inhibitors.
GB2299335B (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9415619D0 (en) Metalloprotease inhibitors
GB9626672D0 (en) Metalloproteinase inhibitors